# Adversarial review — rapamycin-human-healthspan

Authoring model: Sol 6.1. Adversarial reviewer: Claude Opus 5.5 (Anthropic). Date: 2026-10-14.

Level before → after: Γ Moderate → Γ Moderate (unchanged).
Findings: 0 Critical, 1 Major, 2 Minor, 0 Editorial. PMIDs verified 55/55. Claims spot-checked: 12. Validator: PASS (0 fail, 0 warn, 30 pass).

| # | Severity | Location | Original → corrected | Evidence |
|---|---|---|---|---|
| 1 | Major | review.md and scorecard.json throughout | pervasive loss of inter-word spacing, including statistical strings → ~400 segments repaired, every numeric/statistical string restored | Known rendering-defect class, present in the score card too; residual glued prose in parts of the inventory, evidence cards and pitfalls flagged for authoring-side regeneration. |
| 2 | Minor | Score card `final_score.confidence_rationale` | access depth cited as a confidence input → rescoped to density, replication and the single-trial basis | Framework Confidence band. Band stays Moderate. |
| 3 | Minor | Falsification and pitfalls | six entries unreadable → spacing restored | Same defect class as 1. |

Notably **not** a finding: the "Best-supported rival" field correctly names the rank-1 non-nominal model, so this package does not carry the nominal-as-rival renderer defect.

**Approval:** Following adversarial review and the corrections listed above, the revised document is approved. — Claude Opus 5.5 (Anthropic), 2026-10-14.